Compare Spectral Medical, Inc. with Similar Stocks
Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 0.81% and Operating profit at -8.36% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.33
2
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
CAD 374 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.21
17.57%
-5.45
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Sep 2025)
Net Profit:
-30 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.57%
0%
-1.57%
6 Months
-15.54%
0%
-15.54%
1 Year
89.39%
0%
89.39%
2 Years
197.62%
0%
197.62%
3 Years
267.65%
0%
267.65%
4 Years
257.14%
0%
257.14%
5 Years
140.38%
0%
140.38%
Spectral Medical, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.25%
EBIT Growth (5y)
-7.98%
EBIT to Interest (avg)
-8.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
-0.15
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-5.45
EV to EBIT
-32.81
EV to EBITDA
-33.51
EV to Capital Employed
-7.19
EV to Sales
143.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Dec 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
0.70
0.50
40.00%
Operating Profit (PBDIT) excl Other Income
-3.10
-3.00
-3.33%
Interest
1.40
1.00
40.00%
Exceptional Items
-27.50
-6.20
-343.55%
Consolidate Net Profit
-30.30
-10.00
-203.00%
Operating Profit Margin (Excl OI)
-4,644.40%
-6,185.30%
154.09%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 40.00% vs 25.00% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -203.00% vs -203.03% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2.30
1.60
43.75%
Operating Profit (PBDIT) excl Other Income
-11.70
-11.20
-4.46%
Interest
3.20
1.30
146.15%
Exceptional Items
2.50
-2.20
213.64%
Consolidate Net Profit
-15.40
-15.50
0.65%
Operating Profit Margin (Excl OI)
-5,248.00%
-7,147.10%
189.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 43.75% vs -5.88% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 0.65% vs -103.95% in Dec 2023
About Spectral Medical, Inc. 
Spectral Medical, Inc.
Pharmaceuticals & Biotechnology
Spectral Medical Inc. is a late stage theranostic company advancing therapeutic options for sepsis and septic shock. The Company has developed a product for the treatment of patients with septic shock, Toraymyxin (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA). The EAA is a rapid in-vitro diagnostic test that measures negative bacterial cell wall (endotoxin) activity in a whole blood sample. The Company, through its wholly owned subsidiary, Dialco Medical Inc. (Dialco), is also commercializing a new platform, SAMI. Its platform is targeting the renal replacement therapy (RRT) market.
Company Coordinates 
Company Details
135 - 2 The West Mall , TORONTO ON : M9C 1C2
Registrar Details






